Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03589222
Brief Title: SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

First Submitted : June 12, 2018
First Submitted that Met QC Criteria : July 4, 2018
First Posted : July 17, 2018

Last Update Submitted that Met QC Criteria : July 26, 2018
Last Update Posted : July 27, 2018